NasdaqGM - Delayed Quote • USD
Cerus Corporation (CERS)
At close: April 22 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 5 |
| Avg. Estimate | -0.05 | -0.03 | -0.1 | -0.06 |
| Low Estimate | -0.07 | -0.04 | -0.13 | -0.09 |
| High Estimate | -0.04 | -0.02 | -0.08 | -0.04 |
| Year Ago EPS | -0.09 | -0.07 | -0.21 | -0.1 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 41.14M | 47.23M | 190.89M | 213.54M |
| Low Estimate | 36.4M | 42.5M | 173.3M | 195.2M |
| High Estimate | 44.8M | 50.6M | 200M | 236.5M |
| Year Ago Sales | 30.97M | 38.85M | 156.37M | 190.89M |
| Sales Growth (year/est) | 32.80% | 21.60% | 22.10% | 11.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.07 | -0.06 | -0.05 | -0.02 |
| EPS Actual | -0.09 | -0.07 | -0.04 | -0.01 |
| Difference | -0.02 | -0.01 | 0.01 | 0.01 |
| Surprise % | -28.60% | -16.70% | 20.00% | 50.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.05 | -0.03 | -0.1 | -0.06 |
| 7 Days Ago | -0.05 | -0.03 | -0.1 | -0.06 |
| 30 Days Ago | -0.05 | -0.03 | -0.1 | -0.06 |
| 60 Days Ago | -0.05 | -0.03 | -0.11 | -0.06 |
| 90 Days Ago | -0.05 | -0.03 | -0.11 | -0.06 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CERS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 44.40% | -- | -- | 0.20% |
| Next Qtr. | 57.10% | -- | -- | 9.40% |
| Current Year | 52.40% | -- | -- | 4.40% |
| Next Year | 40.00% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.07% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Craig-Hallum: Buy | 4/12/2024 |
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 3/7/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/6/2024 |
| Downgrade | BTIG: Buy to Neutral | 1/20/2023 |
| Maintains | Stifel: Buy | 5/27/2020 |
| Maintains | Stephens & Co.: Overweight | 4/16/2020 |
Related Tickers
RCEL AVITA Medical, Inc.
8.55
-1.04%
CTSO Cytosorbents Corporation
0.8100
+1.00%
ICAD iCAD, Inc.
1.5200
-1.30%
DCTH Delcath Systems, Inc.
5.51
+13.14%
FNA Paragon 28, Inc.
9.79
-0.10%
NVNO enVVeno Medical Corporation
4.9100
+6.28%
SGHT Sight Sciences, Inc.
5.37
+4.68%
BFLY Butterfly Network, Inc.
0.7209
-5.72%
AXGN AxoGen, Inc.
6.86
+5.54%
CVRX CVRx, Inc.
14.69
-1.41%